ResearcherHokkaido UniversityNo recent work listed
Masato Ono
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers
Papers 4
- Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9. Co-author DOI 10.1245/s10434-022-11630-0↗
- ASO Author Reflections: Constructed Scoring System Using TP53 and SMAD4 Mutations Combined with Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-022-11735-6↗
- Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.14023↗
- Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. Co-author DOI 10.18632/oncotarget.21939↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toru Nakamura · 4 shared papers, 2017–2022 · strength 0.46
- Paper ASO Author Reflections: Constructed Scoring System Using TP53 and SMAD4 Mutations Combined with Carbohydrate Antigen 19… DOI 10.1245/s10434-022-11735-6↗
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Satoshi Hirano · 4 shared papers, 2017–2022 · strength 0.46
- Paper ASO Author Reflections: Constructed Scoring System Using TP53 and SMAD4 Mutations Combined with Carbohydrate Antigen 19… DOI 10.1245/s10434-022-11735-6↗
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Yusuke Mizukami · 2 shared papers, 2022 · strength 0.34
- Paper ASO Author Reflections: Constructed Scoring System Using TP53 and SMAD4 Mutations Combined with Carbohydrate Antigen 19… DOI 10.1245/s10434-022-11735-6↗
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Takahiro Tsuchikawa · 3 shared papers, 2017–2022 · strength 0.24
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Shota Kuwabara · 3 shared papers, 2017–2022 · strength 0.24
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Toshiaki Shichinohe · 2 shared papers, 2019–2022 · strength 0.19
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Yoshitsugu Nakanishi · 2 shared papers, 2019–2022 · strength 0.19
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Toshimichi Asano · 2 shared papers, 2019–2022 · strength 0.19
- Paper Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scor… DOI 10.1245/s10434-022-11630-0↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Osamu Sato · 2 shared papers, 2017–2019 · strength 0.13
- Yuko Omori · 1 shared paper, 2022 · strength 0.11
- Toru Furukawa · 1 shared paper, 2022 · strength 0.11
- Yuma Hane · 1 shared paper, 2019 · strength 0.07
- Hironobu Takano · 1 shared paper, 2017 · strength 0.05
- Shoki Sato · 1 shared paper, 2017 · strength 0.05
- Kazuho Inoko · 1 shared paper, 2017 · strength 0.05
- Shintaro Takeuchi · 1 shared paper, 2017 · strength 0.05
- Toshihiro Kushibiki · 1 shared paper, 2017 · strength 0.05
- Yusuke Nakamura · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.